Why the study?
Use of the PRECISE-DAPT score to guide DAPT duration had not been properly validated by randomized trials focused on patients with acute coronary syndrome.
Does 6-month DAPT compared to 12-month or longer DAPT improve clinical outcomes when guided by the PRECISE-DAPT score in patients with acute coronary syndrome undergoing percutaneous coronary intervention?
Does 6-month DAPT compared to 12-month or longer DAPT improve clinical outcomes when guided by the PRECISE-DAPT score in patients with acute coronary syndrome undergoing percutaneous coronary intervention?
Determination of DAPT duration according to the PRECISE-DAPT score could improve clinical outcomes in ACS patients after PCI with current-generation drug-eluting stents.
Answers are grounded in this paper and cite their sources.
Supports score-guided DAPT duration in ACS-PCI; extends randomized evidence to current-generation drug-eluting stents.
BACKGROUND: Although the current guidelines endorse the PRECISE-DAPT score (Predicting Bleeding Complications in Patients Undergoing Stent Implantation and Subsequent Dual Antiplatelet Therapy) to inform clinical decisions regarding duration of DAPT in patients undergoing percutaneous coronary intervention, use of the PRECISE-DAPT score to guide duration of DAPT has not been properly validated by randomized trials focused on the population with acute coronary syndrome. This study aimed to evaluate the usefulness of the PRECISE-DAPT score for predicting future bleeding and ischemic events and to compare clinical outcomes of short-term and long-term DAPT duration according to the PRECISE-DAPT score in patients with acute coronary syndrome. METHODS: This was a substudy of the SMART-DATE trial (6- Versus 12-Month or Longer Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome), in which patients with acute coronary syndrome undergoing percutaneous coronary intervention were randomly assigned to either 6- (n=1357) or 12-month or longer DAPT (n=1355). Major bleeding (Bleeding Academic Research Consortium type 3-5) and ischemic (myocardial infarction, stent thrombosis, or ischemic stroke) events at 18 months after the index procedure were compared between the 6- and 12-month or longer DAPT groups, according to PRECISE-DAPT score. CONCLUSIONS: Consistent with current guidelines, determination of the duration of DAPT according to PRECISE-DAPT score could improve the clinical outcomes in patients with acute coronary syndrome after percutaneous coronary intervention with current-generation drug-eluting stents. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT01701453.
No takes yet. Share an insight, caveat, or question.
Choi et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: